Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Why is Jilin Jian Yisheng Pharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -6.34% and Operating profit at -17.43% over the last 5 years

The company has declared Negative results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 71.1 MM
ROCE(HY) Lowest at 1.82%
INVENTORY TURNOVER RATIO(HY) Lowest at 0.11 times

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jilin Jian Yisheng Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

8.67%

0.65

35.14%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-6.34%

EBIT Growth (5y)

-17.43%

EBIT to Interest (avg)

5.93

Debt to EBITDA (avg)

0.38

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.27

Tax Ratio

15.50%

Dividend Payout Ratio

63.53%

Pledged Shares

Institutional Holding

ROCE (avg)

3.70%

ROE (avg)

3.80%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.18

EV to EBIT

93.90

EV to EBITDA

34.16

EV to Capital Employed

1.19

EV to Sales

4.03

PEG Ratio

Dividend Yield

0.78%

ROCE (Latest)

1.26%

ROE (Latest)

1.63%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -10.39% (YoY

CASH AND EQV(HY)

Highest at CNY 1,126.38 MM

-17What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 71.1 MM

ROCE(HY)

Lowest at 1.82%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.11 times

INTEREST COVERAGE RATIO(Q)

Lowest at 193.54

PRE-TAX PROFIT(Q)

At CNY 5.82 MM has Fallen at -43.54%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.82 times

NET SALES(Q)

Lowest at CNY 148.37 MM

OPERATING PROFIT(Q)

Lowest at CNY 6.57 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.43 %

NET PROFIT(Q)

At CNY 5.76 MM has Fallen at -37.07%

Here's what is working for Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Cash and Eqv

Highest at CNY 1,126.38 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -10.39% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Operating Cash Flow

Lowest at CNY 71.1 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest Coverage Ratio

Lowest at 193.54

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Pre-Tax Profit

At CNY 5.82 MM has Fallen at -43.54%

over average net sales of the previous four periods of CNY 10.3 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 0.11 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

Lowest at CNY 148.37 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 148.37 MM has Fallen at -7.9%

over average net sales of the previous four periods of CNY 161.1 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 6.57 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.43 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Profit

At CNY 5.76 MM has Fallen at -37.07%

over average net sales of the previous four periods of CNY 9.16 MM

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Debtors Turnover Ratio

Lowest at 2.82 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio